זומרה ® 4 מ"ג/5 מ"ל

País: Israel

Idioma: hebreu

Font: Ministry of Health

ingredients actius:

ZOLEDRONIC ACID 4 MG/VIAL

Disponible des:

NOVARTIS PHARMA SERVICES AG

Codi ATC:

M05BA08

formulario farmacéutico:

CONCENTRATE FOR SOLUTION FOR INFUSION

Vía de administración:

I.V

Fabricat per:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Grupo terapéutico:

ZOLEDRONIC ACID

indicaciones terapéuticas:

Treatment of hypercalcaemia of malignancy. Treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors , in conjunction with standard antineoplastic therapy. Prostate cancer should have progressed after treatment with at least one hormonal therapy.

Data d'autorització:

2013-11-01